Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

USA - NASDAQ:OSUR - US68554V1089 - Common Stock

3.01 USD
+0.06 (+2.03%)
Last: 10/13/2025, 8:00:02 PM
3.01 USD
0 (0%)
After Hours: 10/13/2025, 8:00:02 PM
Fundamental Rating

2

Overall OSUR gets a fundamental rating of 2 out of 10. We evaluated OSUR against 191 industry peers in the Health Care Equipment & Supplies industry. The financial health of OSUR is average, but there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OSUR had negative earnings in the past year.
In the past year OSUR has reported a negative cash flow from operations.
OSUR had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

OSUR has a Return On Assets of -11.47%. This is comparable to the rest of the industry: OSUR outperforms 58.12% of its industry peers.
The Return On Equity of OSUR (-13.40%) is better than 62.83% of its industry peers.
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

The Gross Margin of OSUR (40.49%) is worse than 65.97% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.49%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSUR has been increased compared to 1 year ago.
The number of shares outstanding for OSUR has been increased compared to 5 years ago.
Compared to 1 year ago, OSUR has an improved debt to assets ratio.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OSUR has an Altman-Z score of 2.18. This is not the best score and indicates that OSUR is in the grey zone with still only limited risk for bankruptcy at the moment.
OSUR's Altman-Z score of 2.18 is fine compared to the rest of the industry. OSUR outperforms 64.40% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
The Debt to Equity ratio of OSUR (0.00) is better than 74.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACCN/A
WACC8.68%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

OSUR has a Current Ratio of 7.12. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OSUR (7.12) is better than 86.39% of its industry peers.
OSUR has a Quick Ratio of 6.33. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 6.33, OSUR belongs to the top of the industry, outperforming 87.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.12
Quick Ratio 6.33
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -286.11%.
The Revenue for OSUR has decreased by -49.36% in the past year. This is quite bad
The Revenue has been growing slightly by 3.75% on average over the past years.
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%

3.2 Future

Based on estimates for the next years, OSUR will show a very strong growth in Earnings Per Share. The EPS will grow by 25.37% on average per year.
The Revenue is expected to decrease by -4.62% on average over the next years.
EPS Next Y-229.54%
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

A cheap valuation may be justified as OSUR's earnings are expected to decrease with -28.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%

More info and screens

0

5. Dividend

5.1 Amount

OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (10/13/2025, 8:00:02 PM)

After market: 3.01 0 (0%)

3.01

+0.06 (+2.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners92.79%
Inst Owner Change-0.17%
Ins Owners4.8%
Ins Owner Change8.23%
Market Cap220.15M
Analysts82.5
Price Target6.12 (103.32%)
Short Float %5.59%
Short Ratio6.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.39%
Min EPS beat(2)-24.34%
Max EPS beat(2)-0.43%
EPS beat(4)1
Avg EPS beat(4)-35.92%
Min EPS beat(4)-142.2%
Max EPS beat(4)23.28%
EPS beat(8)4
Avg EPS beat(8)-43.86%
EPS beat(12)8
Avg EPS beat(12)205%
EPS beat(16)8
Avg EPS beat(16)106.42%
Revenue beat(2)2
Avg Revenue beat(2)0.73%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.89%
Revenue beat(4)3
Avg Revenue beat(4)0.43%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)0.89%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)10.24%
Revenue beat(16)15
Avg Revenue beat(16)9.83%
PT rev (1m)0%
PT rev (3m)33.33%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)-17.65%
EPS NY rev (1m)-12.75%
EPS NY rev (3m)-12.75%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-14.74%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-5.16%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 0.58
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.23
OCFYN/A
SpS1.89
BVpS5.21
TBVpS4.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.47%
ROE -13.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.49%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score3
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.19%
Cap/Sales 2.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.12
Quick Ratio 6.33
Altman-Z 2.18
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-286.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2500%
EPS Next Y-229.54%
EPS Next 2Y-60.3%
EPS Next 3Y-28.43%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-49.36%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-42.5%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-528.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-140.24%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-127.86%
OCF growth 3YN/A
OCF growth 5Y22.81%